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2',3'-epoxyisocapnolactone and 8-hydroxyisocapnolactone-2',3'-diol are two bioactive 
compounds isolated from the leaves of Mzcromelum minutum. The cytotoxic effect of the 
compounds was tested on a variety of human cell lines respectively using MTT assay. 
They were found to be most sensitive against human T-lymphoblastic leukemia cells 
(CEM-SS). The inhibition effect of 2',3'-epoxyisocapnolactone and 8- 
hydroxyisocapnolactone-2',3'-diol at 50% of cell population (ICso) was found to be 4.6 
pg/ml (13.5 pM) and 3 pdml (7.8 pM) on CEM-SS cells, respectively. Besides that, the 
inhibitor effect of the compounds on other human cells were found to be 13.4 pdml(39.2 
pM) and 9.0 pdml(23.9 pM) on cervical carcinoma cells (HeLa), 14.2 pg/ml (41.5 pM) 
and 7.7 pdml (20.5 pM) on colon adenocarcinoma cells (HT29), 7.4 pg/ml (21.6 pM) 
and 5.9 pdml (1 5.7 pM) on hepatocarcinoma cells (HepG2), 6.5 pglml (19.0 pM) and 
7.1 pg/ml(18.9 pM) on transform liver cells (Chang). For comparative purposes, the ICW 
of several clinical cytotoxic drugs against CEM-SS cells were determined. The inhibitor 
effect of the compounds were more significant compared with methotrexate [ICm = >30 
pg/ml (66.1 pM)], cytosine arabinoside [IC5o = >30 pg/ml (123.5 pM)] and colchicines 
[IC50 = 8 pglml (20.1 pM)] The compounds also shown near similar ICso concentration 
as compare with cis-diamine dichloroplatinum [IC50 = 3 pg/ml (10.1 pM)], vinorelbine 
[IC50 = 3 pg/ml (3.9 pM)] and doxorubicin [IC5o = 2.4 pg/ml (4.1 pM)]. Furthermore, 
from proliferation assay study, the compounds were significantly inhibiting the 
proliferation of cells at ICso value. From the morphological observation and agarose gel 
electrophoresis, apoptosis of the compounds on CEM-SS cells was determined. By using 
phase contrast, fluorescence and electron microcopies, observation on morphological 
alterations indicating apoptosis was evaluated. From DNA fragmentation, Acridine 
orange and Propidium iodide staining and DNA content analyses, the compounds were 
confirmed to  have ability in promoting apoptosis. However, the percentage of apoptosis 
induced is low and the event is time-dependent. At high concentration of 10 pg/m, 2',3'- 
epoxyisocapnolactone and 8-hydroxyisocapnolactone-2',3'-diol induced necrosis. 
Furthermore, 8-hydroxyisocapnolactone-2',3'-diol also exhibited better cytotoxicity 
compared to 2',3'-epoxyisocapnolactone. The induction time for apoptosis by 8- 
hydroxyisocapnolactone-2',3'-diol in CEM-SS is earlier than 2',3'-epoxyisocapnolactone, 
which is 4 hours and 12 hours after treatment. Based on the results obtained, 2',3'- 
epoxyisocapnolactone and 8-hydroxyisocapnolactone-2',3'-diol are able to induced 
apoptosis. 
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2',3'-epoxyisocapnolactone dan 8-hydroxyisocapnolactone-2',3'-diol merupakan dua 
jenis sebatian yang diasingkan dari daun Micromelum minutum. Kesan sitotoksik oleh 
kedua-dua sebatian ke atas pertumbuhan perbagai jenis jujukan kanser sel manusia telah 
diuji dengan teknik MTT. Mereka didapati lebih sensitive ke atas jujukan sel T- 
lymphoblastik leukemik manusia (CEM-SS). Kesan perencatan oleh 2',3'- 
epoxyisocapnolactone and 8-hydroxyisocapnolactone-2',3'-diol pada 50% dari sel 
populasi (I(&) didapati sebanyak 4.6 pglml (13.5 pM) dan 3 pg/ml (7.8 pM) masing- 
masing ke atas sel CEM-SS. Selain itu, kesan perencatan oleh kedua-dua sebatian aktif di 
atas jujukan sel manusia yang lain juga didapati sebanyak 13.4 pg/ml (39.2 pM) dan 9.0 
pglml (23.9 pM) ke atas sel servikal karsinoma (HeLa), 14.2 pg/m1 (41.5 pM) dan 7.7 
pg/ml (20.5 pM) ke atas sel adenokarsinoma usus (HT29), 7.4 pglml (21.6 pM) dan 5.9 
pg/ml (15.7 pM) ke atas sel hepatokarsinoma (HepG2), 6.5 pg/ml (19.0 pM) dan 7.1 
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pg/ml (18.9 pM) ke atas sel hati yang normal (Chang). Sebagai bandingan, ICso dari 
beberapa jenis ubat pasaran ke atas sel CEM-SS juga diujikan. Kesan perencatan oleh 
kedua-dua sebatian semulajadi adalah lebih berkesan berbanding dengan ubat-ubatan 
pasaran seperti methotrexate [ICw, = >30 pglml (66.1 pM)], cytosine arabinoside [I& = 
>30 pg/m1 (123.5 pM)] dan colchicines [ICso = 8 pg/ml (20.1 pM)]. Kedua-dua sebatian 
juga menunjukan aktiviti ICso yang agak sarna berbanding dengan cis-diamine 
dichloroplatinum [ICso = 3 pgtml (lo. 1 phi)], vinorelbine [ICso = 3 pglml (3.9 pM)] dan 
doxorubicin [ICso = 2.4 pg/ml (4.1 pM)] Selain itu, dari pengajian atas teknik 
pertumbuhan, kedua-dua sebatian adalah ketara dalam perencatan pertumbuhan sel pada 
IClo. ~esan-ipoptosis bagi kedua-dua sebatian aktif ke atas sel CEM-SS tdah diperolehi 
daripada pemerhatian morfblogi dan elektrophoresis gel agaros. Dengan mengunakan 
teknik mikroskop fasa perbezaan, fluoresent dan elektron, pemerhatian ke atas perbezaan 
morfologi yang berkaitan dengan apoptosis telah dijalankan. Dari keputusan DNA 
fiagmentasi, pewarnaan AO/PI dan pengajian kandungan DNA, kedua-dua sebatian aktif- 
telah menunjukan kebolehannya dalam menrangsangkan induksi apoptosis. Akan tetapi, 
peratus bagi induksi apoptosis adalah rendah and kemunculan kesan apoptosis adalah 
bergantung pada masa rawatan. Bila ZY,3'-epoxyisocapnolactone and 8- 
hydroxyisocapnolactone-27-diol dirawat dengan dos yang tinggi (10 pg/ml), ia akan 
menrangsangkan nekrosis. Selebih daripada itu, 8-hydroxyisocapnolactone-2',3'-diol 
juga menunjukkan aktiviti sitotoksik yang lebih baik berbanding dengan 2',3'- 
epoxyisocapnolactone. Kemunculan kesan apoptosis di dalam 8-hydroxyisocapnolactone- 
2',3'-diol adalah lebih awal berbanding dengan 2',3'-epoxyisocapnolactone, iaitu 4 jam 
and 12 jam selepas rawatan. Berdasarkan keputusan yang diperolehi, kedua-dua sebatian 
semulajadi (2',3'-epoxyisocapnolactone and 8-hydroxyisocapnolactone-2',3'-diol) boleh 
disimpulkan sebagai agen sitotoksik potensi yang boleh merangsangkan apoptosis. 
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CHAPTER 1 
INTRODUCTION 
Cancer chemotherapy, the treatment or control of cancer using anticancer drugs which 
are highly toxic medications that destroy cancer cells by interfering with their growth or 
preventing their reproduction (Altrnan and Sarg, 1992). It has played a role in cancer 
treatment for almost half a century. Years of testing and research have proved 
chemotherapy to be an effective cancer treatment. It may be the only treatment, or it may 
be used in combination with other treatments, including surgery and radiation therapy. 
Chemotherapy works by killing rapidly dividing cells. These cells include cancer cells, 
which continuously divide to produce more cells, and healthy cells that divide quickly, 
such as those in bone marrow, gastrointestinal tract, reproductive system and hair 
follicles. Healthy cells usually recover shortly after chemotherapy is complete (Mayo 
Foundation for Medical Education and Research, 2003). It differs from surgery or 
radiation in that it is always used as a systemic treatment. In chemotherapy the medicines 
travel throughout the whole body or system rather than being confined or localized to one 
area such as the breast, lung, or colon. Thus chemotherapy can reach cancer cells that 
may have spread to other parts of the body. 
More than 100 drugs are currently used for chemotherapy, either alone or in combination. 
Many more are expected to become available. These chemotherapy medicines are vary 
widely in their chemical composition, how they are taken, their usefulness in treating 
specific forms of cancer, and their side effects. New medications are first developed 
through laboratory research in test tubes and animals. Then, their safety and effectiveness 
are tested for clinical trials in humans (American Cancer Society, 2001). 
Chemotherapy drugs are divided into several categories based on how they affect specific 
chemical substances within cancer cells, which cellular activities or processes the drug 
interferes with, and which specific phases of the cell cycle the drug affects. Most 
chemotherapy is given as a combination of drugs that work together to kill cancer cells. 
Some of the types of chemotherapy medications commonly used to treat cancer include: 
1) Alkylating agents. These medications interfere with the growth of cancer cells by 
blocking the replication of DNA. Examples of alkylating agents include busulfan, 
cisplatin, carboplatin, chlorambucil, cyclophosphamide, ifosfamide, dacarbazine (DTIC), 
mechlorethamine (nitrogen mustard), and melphalan. 2) Antimetabolites. These drugs 
block the enzymes needed by cancer cells to live and grow. Examples of antimetabolites 
include 5-fluorouracil, capecitabine, methotrexate, gemcitabine, cytarabine (ara-C), and 
fludarabine. 3) Antitumor antibiotics. These antibiotics are different from those used to 
treat bacterial infections. It interferes with DNA, blocking certain enzymes and cell 
division, and changing cell membranes. Examples of antitumor antibiotics include 
dactinomycin, daunorubicin, doxorubicin (Adriamycin), idarubicin, and mitoxantrone. 4) 
Mitotic inhibitors. These drugs inhibit cell division or hinder certain enzymes necessary 
in the cell reproduction process. Examples of mitotic inhibitors include paclitaxel, 
docetaxel, etoposide (VP-16), vinblastine, vincristine, and vinorelbine. 5) Nitrosoureas. 
These medications impede the enzymes that help repair DNA. Examples of nitrosoureas 
include carmustine (BCNU) and lomustine (CCNU) (American Cancer Society, 2001). 
Previous studies have demonstrated that a wide range of anticancer agents, including 
chemotherapeutic agents, hormones, and various biologicals, induce apoptosis in 
malignant cells in vitro (Mesner et al, 1997; Kaufmann and Earnshaw, 2000). It is 
important to emphasize that this treatment-induced apoptosis is not merely a tissue 
culture phenomenon. Serial examination of peripheral blood mononuclear cells from 
acute leukemia patients undergoing induction therapy has demonstrated that various 
agents, including cytarabine, mitoxantrone, etoposide, paclitaxel, and topotecan, cause a 
marked increase in the number of apoptotic blasts (Li et al, 1994). Characteristic 
apoptotic changes have also been described in solid tumors after treatment of mice with 
various cytotoxic drugs, including cytarabine, 5-fluorouracil (5FU), fludarabine, 
doxorubicin, cyclophosphamide, cisplatin, etoposide, dactinomycin, and camptothecin 
(Kaufmann and Earnshaw, 2000). 
For chemotherapy, natural products have been important sources of medicines for many 
traditional communities around the world. Natural products or their structural relatives 
comprise about 50% of the drugs that are used in cancer chemotherapy (Mann, 2002). In 
Malaysia, out of 12,000 species of higher plants which are found in this country, that are 
more than 1,000 species are said to have therapeutic properties and currently being used 
in the local traditional medicine system (Said, 1995). According to another report by 
Burkill in 1966, there are about 6,000-7,000 species of higher plants that have been 
reported to have therapeutic or medicinal properties in Peninsular Malaysia and its 
surrounding islands (Burkill, 1966). Since the used of natural products in cancer 
chemotherapy have growth tremendously, the study of mechanism and mode of action of 
plant extracts become more and more important. In many research, plant related 
derivatives can be synthesized by knowing their biochemical reaction against cancer, and 
these derivatives can even have greater effect over the original compounds. 
In this study, two natural compounds, 2',3'-epoxyisocapnolactone and 8- 
hydroxyisocapnolactone-2',3'-diol, which were isolated from the leaves of Micromelum 
minuturn, were tested for their cytotoxic activity against human T-lymphoblastic 
leukemia cells (CEMSS) 
The objectives of this study were: 
To evaluate the cytotoxic and antiproliferative activities of 2',3'- 
epoxyisocapnolactone and 8-hydroxyisocapnolactone-2',3 '-diol against human T- 
lymphoblastic leukemic cells (CEM-SS) in terms of proliferation, morphoIogica1 
changes and the mode of cell death. 
To investigate the induction of apoptosis by 2',3'-epoxyisocapnolactone and 8- 
hydroxyisocapnolactone-2',3'-diol in treated CEM-SS cells. 
CHAPTER 2 
LITERATURE REVIEW 
2.1 Cancer 
Cancer, a general term for more than 100 diseases which characterized by an 
uncontrolled, abnormal growth of cells appear in different parts of the body that can 
spread to other parts of the body (Altman and Sarg, 1992). It is a potentially fatal disease 
caused mainly by environmental factors that mutate genes encoding critical cell- 
regulation proteins. The resultant aberrant cell behavior leads to expensive masses of 
abnormal cells that destroy surrounding normal tissue and can spread to vital organs 
resulting in disseminated, commonly a harbinger of imminent patient death (Alison, 
2002). Cancer cells contain many genetic alterations that accumulate as tumors develop. 
Over the last 20 years, considerable information has been gathered on regulation of cell 
growth and proliferation leading to the identification of the involvement of specific 
genes at the molecular level (Macdonald and Ford, 1997). 
The incident of cancer is rising with doubling in new cancer cases and cancers related 
deaths expected over the next 20 years (Alison, 2002). Part of the reason for this rise is 
that life expectancy is steadily rising and most cancers are more common in an ageing 
population. More significantly, a globalization of unhealthy lifestyles, particularly 
